Understand the source comparison
P21 versus Semax
Semax is an analogue of adrenocorticotropic hormone, or ACTH, designed in Russia where it has been on the official List of Vital and Essential Drugs since 2011. It is approved there for stroke, memory disorders, ulcers, optic nerve disease, and immune system s
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semax is an analogue of adrenocorticotropic hormone, or ACTH, designed in Russia where it has been on the official List of Vital and Essential Drugs since 2011. It is approved there for stroke, memory disorders, ulcers, optic nerve disease, and immune system support. Unlike P21, Semax has been tested and used clinically in humans, giving it a significantly larger safety and efficacy database.
- Both peptides increase BDNF levels, but through different mechanisms. P21 works through LIF inhibition and CNTF pathway modulation. Semax works through ACTH-receptor-mediated pathways, affecting serotonergic and dopaminergic systems. The result is that while both enhance cognition, they produce different cognitive profiles. Semax tends to improve attention, memory retention, and mood, with documented anxiolytic and antidepressant effects. P21 focuses more specifically on neurogenesis and neuroprotection.
- Semax also has one practical advantage: established clinical use. It has been through human testing. P21 has not. For researchers prioritizing compounds with human data behind them, Semax is the safer bet.